June 2, 2010: VentriPoint Announces Installation of Its VMS 3D Cardiac Technology in Toronto's Hospital
for Sick Children
February 1, 2010: VentriPoint Announces Proposed Private Placement
January 27, 2010: VentriPoint to Present Clinical Validation Study at American College of
Cardiology 59th Annual Scientific Session in March
January 20, 2010: VentriPoint Announces Acceptance of Second Clinical Validation Study for Publication
January 13, 2010: VentriPoint and Hospital For Sick Children Enter Into a MOU for Installation
of VentriPoint Medical System
December 10, 2009: VentriPoint Announces European CE Mark Approval of Critical Cardiac Diagnostic System
September 12, 2009: VentriPoint Announces Acceptance of Clinical Validation Study for Publication
March 9, 2009:
VENTRIPOINT DIAGNOSTICS ANNOUNCES INITIAL CLOSING OF CURRENT OFFERING
AND SUBMISSION FOR EUROPEAN REGULATORY APPROVAL
February 19, 2009: VENTRIPOINT DIAGNOSTICS RECEIVES HEALTH CANADA
REGULATORY APPROVAL TO SELL DEVICE;
QUALITY ASSURED THROUGH ISO CERTIFICATION
December 8,2008:
VENTRIPOINT DIAGNOSTICS’ THIRD QUARTER PROGRESS HAS
MOVED UP COMMERCIAL LAUNCH DATE
December 8,2008:
VENTRIPOINT DIAGNOSTICS’ OFFERS SECURED DEBENTURE FINANCING
October 20, 2008: VentriPoint Diagnostics Ltd. Secures $1 Million Bridge Loan to Support Beta Trials
October 2, 2008: VentriPoint Diagnostics LTD. engages CHF investor relations
and reports approval of shares issued to directors and consultants as payment for services
September 10, 2008: VentriPoint Diagnostics Announces Private Placement of Equity Financing
August 29,2008: VentriPoint Diagnostics Files Management Discussion and
Analysis, Unaudited Financial Results for 2Q 2008
July 1, 2008: VentriPoint Appoints Mary-Pierre Waiss Vice President of Clinical Development
June 3, 2008: VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial
Results for Q1, 2008
May 8, 2008: Medical Device Daily: VentriPoint develops better method of RV measurement
Written after the completion of the tetralogy of fallot database, the article discusses the medical need for
accurate measurements of the right ventricle and how the VentriPoint Diagnostic System fills this need.
The article also provides a brief overview of how VentriPoint’s Knowledge Based Reconstruction technique
creates accurate 3-dimensional models and volume measurements of the right ventricle.
View the full article on-line here. (Subscription required)
April 30, 2008: VentriPoint Diagnostics Files Management Discussion and
Analysis, Audited Financial Results
April 29, 2008: Knowledge Based Reconstruction Demonstrates Accuracy in
Obtaining Ventricular
Volume and Function in Tetralogy of Fallot
Patients
April 24, 2008: VentriPoint, University of Washington Sign Research
and Technology Development agreement
April 8, 2008: Three Dimensional Visualization of Right Ventricle Provides Important Information
for Treatment of Patients with Tetralogy of Fallot, According to a Study in The
American Journal of Cardiology
March 2008: VentriPoint Diagnostics Announces the Committee Membership of its
Newly Elected Directors
February 2008: VentriPoint Diagnostics Retains Russo Partners
as Communications Counsel
VentriPoint Diagnostics Ltd. is a public Canadian company with its common shares traded on the TSX Venture Exchange under the symbol "VPT", its only operations being those of VentriPoint, Inc.
Complete and continuous disclosure documents, including audited financial statements can be found at: http://www.sedar.com/
